(NASDAQ: SANA) Sana Biotechnology's forecast annual earnings growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast earnings growth rate of 14.46%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 33.74%.
Sana Biotechnology's earnings in 2026 is -$244,166,000.On average, 12 Wall Street analysts forecast SANA's earnings for 2026 to be -$173,169,929, with the lowest SANA earnings forecast at -$201,377,760, and the highest SANA earnings forecast at -$145,709,326. On average, 12 Wall Street analysts forecast SANA's earnings for 2027 to be -$175,838,598, with the lowest SANA earnings forecast at -$206,608,352, and the highest SANA earnings forecast at -$148,511,428.
In 2028, SANA is forecast to generate -$182,750,451 in earnings, with the lowest earnings forecast at -$237,458,165 and the highest earnings forecast at -$148,511,428.